Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, r...
Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial
About this item
Full title
Author / Creator
Miki, Keisuke , Maekura, Ryoji , Nagaya, Noritoshi , Nakazato, Masamitsu , Kimura, Hiroshi , Murakami, Shinsuke , Ohnishi, Shunsuke , Hiraga, Toru , Miki, Mari , Kitada, Seigo , Yoshimura, Kenji , Tateishi, Yoshitaka , Arimura, Yasuji , Matsumoto, Nobuhiro , Yoshikawa, Masanori , Yamahara, Kenichi and Kangawa, Kenji
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Pulmonary cachexia is common in advanced chronic obstructive pulmonary disease (COPD), culminating in exercise intolerance and a poor prognosis. Ghrelin is a novel growth hormone (GH)-releasing peptide with GH-independent effects. The efficacy and safety of adding ghrelin to pulmonary rehabilitation (PR) in cachectic COPD patients were investigated...
Alternative Titles
Full title
Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_1324605261
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1324605261
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0035708
